EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:749608 |
| ChEBI Name | canakinumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| canakinumab (CHEBI:749608) has role anti-anaemic agent (CHEBI:75835) |
| canakinumab (CHEBI:749608) has role anti-arrhythmia drug (CHEBI:38070) |
| canakinumab (CHEBI:749608) has role anti-inflammatory agent (CHEBI:67079) |
| canakinumab (CHEBI:749608) has role antiatherosclerotic agent (CHEBI:145947) |
| canakinumab (CHEBI:749608) has role antimicrobial agent (CHEBI:33281) |
| canakinumab (CHEBI:749608) has role antineoplastic agent (CHEBI:35610) |
| canakinumab (CHEBI:749608) has role antirheumatic drug (CHEBI:35842) |
| canakinumab (CHEBI:749608) has role antiviral agent (CHEBI:22587) |
| canakinumab (CHEBI:749608) has role gout suppressant (CHEBI:35845) |
| canakinumab (CHEBI:749608) has role hyperglycemic agent (CHEBI:76916) |
| canakinumab (CHEBI:749608) has role hypoglycemic agent (CHEBI:35526) |
| canakinumab (CHEBI:749608) has role ophthalmology drug (CHEBI:66981) |
| canakinumab (CHEBI:749608) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| ACZ-885 | ChEMBL |
| ACZ885 | ChEMBL |
| Canakinumab | ChEMBL |
| Brand Name | Source |
|---|---|
| Ilaris | ChEMBL |